Advancements in Dermatology: A Weekly Review
Dermatologia e Venerologia
Herpes Simplex Virus: Why 900 Million Cases Still Elude a Cure
Despite decades of research, herpes simplex virus (HSV) continues to pose significant diagnostic and therapeutic challenges. In this episode, we explore the global burden, the complex biology of viral latency, unexpected clinical presentations, and the latest findings that could reshape prevention and treatment strategies.
Bibliography
- Patel R et al. 2024 European guidelines for the management of genital herpes. J Eur Acad Dermatol Venereol. 2025;39(4):742–758. doi: 10.1111/jdv.20450
- Johnston C et al. Vaccine value profile for herpes simplex virus. Vaccine. 2024;42(19S1):S82–S100. doi: 10.1016/j.vaccine.2024.01.044
- Bai L et al. A review of HSV pathogenesis, vaccine development, and advanced applications. Mol Biomed. 2024;5(1):35. doi: 10.1186/s43556-024-00199-7
- Harfouche M et al. Global incidence and prevalence of HSV and genital ulcer disease in 2020: modelling analyses. Sex Transm Infect. 2025;101(4):214–223. doi: 10.1136/sextrans-2024-056307
- Cao S et al. Recent advances in alphaherpesvirus latency and reactivation. Pathogens. 2024;13(9):779. doi: 10.3390/pathogens13090779
- Sørensen NK et al. Venereal diseases in Denmark. Ugeskr Laeger. 2025;187(17):V05240335. doi: 10.61409/V05240335
- Herbin C et al. Atypical primary HSV-2 infection: case report. J Med Case Rep. 2024;18(1):393. doi: 10.1186/s13256-024-04721-x
- Tugizov S. HIV-1 Tat and disruption of epithelial barriers promoting HSV spread. Front Immunol. 2025;16:1541532. doi: 10.3389/fimmu.2025.1541532
- Avitabile E et al. Protective mechanisms of vaginal lactobacilli against viral STIs. Int J Mol Sci. 2024;25(17):9168. doi: 10.3390/ijms25179168
